Valuation: DIAGNOS Inc.

Market Cap 37.33M 26.63M 23.06M 21.5M 19.77M 2.53B 37.74M 253M 99.15M 1.27B 100M 97.8M 4.2B P/E 2025
-6.18x
P/E 2026 -6.51x
Enterprise Value 36.8M 26.25M 22.74M 21.2M 19.49M 2.5B 37.21M 249M 97.76M 1.25B 98.6M 96.43M 4.14B EV / Sales 2025
293x
EV / Sales 2026 498x
Free-Float
95.61%
Yield 2025 *
-
Yield 2026 -
1 day+3.33%
1 week+8.77%
Current month+12.73%
1 month+14.81%
3 months+47.62%
6 months+6.90%
Current year-17.33%
1 week 0.28
Extreme 0.275
0.34
1 month 0.22
Extreme 0.225
0.36
Current year 0.18
Extreme 0.175
0.38
1 year 0.18
Extreme 0.175
0.42
3 years 0.18
Extreme 0.175
0.59
5 years 0.12
Extreme 0.125
0.59
10 years 0.1
Extreme 0.1
2
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 30/04/2008
Chief Operating Officer - 15/01/2024
Director TitleAgeSince
Director/Board Member - 20/09/2000
Director/Board Member 72 27/09/2020
Chairman 69 29/10/2025
Date Insider Type Main position Quantity % Market Cap.
11/06/26 Option

Director

250,000 0.2076%
26/02/26 Option

Chief Executive Officer

1,200,000 0.9966%
08/12/25 Sell

Chief Executive Officer

83,333 0.0818%
Change 5-day change 1-year change 3-year change Capi.($)
+3.33%+8.77%+19.23%-30.34% 26.63M
+0.33%+4.19%-5.88%+63.56% 222B
+0.02%+12.00%+53.98%+90.10% 110B
+0.18%-1.41%-30.90%-45.28% 104B
-1.66%-2.42%-21.74%-31.89% 91.82B
-3.85%-2.28%-28.30%+1.63% 63.87B
-0.77%+0.86%-18.91%-16.37% 50B
-1.11%-1.31%-8.76%+16.01% 38.42B
+1.27%-6.24%+3.30%+228.80% 38.98B
+2.76%-8.28%+1.36%+94.46% 38.35B
Average -1.08%+0.97%-3.66%+37.07% 75.8B
Weighted average by Cap. -2.18%+1.81%-4.63%+38.00%

Financials

2025 2026
Net sales 104K 74.04K 64.13K 59.78K 54.98K 7.04M 105K 702K 276K 3.52M 278K 272K 11.67M 65.48K 46.71K 40.45K 37.71K 34.68K 4.44M 66.21K 443K 174K 2.22M 175K 172K 7.36M
Net income -4.29M -3.06M -2.65M -2.47M -2.27M -291M -4.33M -29.01M -11.39M -145M -11.48M -11.23M -482M -4.56M -3.25M -2.81M -2.62M -2.41M -309M -4.61M -30.83M -12.1M -155M -12.2M -11.94M -512M
Net Debt -164K -117K -101K -94.28K -86.72K -11.1M -166K -1.11M -435K -5.56M -439K -429K -18.4M -525K -375K -324K -302K -278K -35.62M -531K -3.55M -1.39M -17.82M -1.41M -1.38M -59.03M
Logo DIAGNOS Inc.
Diagnos Inc. is a Canadian company, which is engaged in the early detection of critical eye-related health problems using advanced technology based on Artificial Intelligence (AI). It markets Computer Assisted Retinal Analysis (CARA), a software platform which assists health specialists in the detection of certain retinopathy pathologies through the computerized analysis of retina images. CARA is an in-house-hosted Web-based application that integrates fundus cameras with an image processing engine over a secure Internet connection. The CARA suite of applications allows an eye care specialist to more clearly visualize both normal retinal landmarks (optic nerve, vascular system, macula, fovea), and pathological changes (exudates, haemorrhages, micro-aneurisms, neo-vascularization). CARA is indicated for use by healthcare professionals in an adult general population in the context of a general eye-health exam.
Employees
22
Date Price Change Volume
05/08/26 CA$0.3100 +3.33% 662,735
04/08/26 CA$0.3000 +9.09% 229,877
31/07/26 CA$0.2750 0.00% 63,149
30/07/26 CA$0.2750 -3.51% 268,065
29/07/26 CA$0.2850 -1.72% 754,250

Annual profits - Rate of surprise